-
Staff within the Veterans Affairs (VA) research arm have produced a handbook for veterans considering involvement in clinical trials.
-
A review of nearly 40 years of research of interventions intended to improve informed consent for research participants found mixed results for some of the most popular methods studied. It also revealed a significant lack of good, methodologically sound studies of these informed consent interventions to see which ones work best, says one of the authors.
-
A group of NIH researchers known as the Assembly of Scientists (AOS) is continuing organized opposition to implementation of stringent new conflict-of-interest rules slated for full implementation late this year.
-
Mistrust of the medical and science communities may be discouraging non-Caucasian cancer patients from enrolling in clinical trials, a research group has discovered.
-
The Medical College of Wisconsin is enlisting technology in the task of teaching investigators and research participants about the importance of obtaining truly informed consent in clinical research.
-
More IRBs are being drawn into the complex and controversial world of human embryonic stem cell research.
-
The federal Office for Human Research Protections (OHRP) is seeking public comment through May 24 on recommendations regarding the use of human subjects protection procedures of foreign countries in overseas research.
-
Support groups for people who suffer from chronic or life-threatening illnesses can be a valuable source of community members for IRBs, says a woman who founded a support group and serves on two boards.
-
A survey of warning letters sent to IRBs by the FDA shows that most of the offenders were deficient in some of the most fundamental areas of responsibility failing to have or follow adequate review procedures and failure to maintain adequate documentation of IRB activities.
-
Individual states, including California, Illinois, Massachusetts, New Jersey, New York, and Wisconsin, now are moving forward to fill the funding gap for stem cell research. So far, California leads the pack voters approved a $3 billion bond measure for stem cell research in November.